Related references
Note: Only part of the references are listed.Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer
Kojiro Omiya et al.
ANNALS OF SURGERY (2023)
Tips and tricks for robotic pancreatoduodenectomy with superior mesenteric/portal vein resection and reconstruction
Emanuele F. Kauffmann et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)
A Paradigm Shifts: Neoadjuvant Therapy for Clearly Resectable Pancreatic Cancer
Susanna W. L. de Geus et al.
ANNALS OF SURGICAL ONCOLOGY (2023)
Pancreatectomy with resection and reconstruction of the superior mesenteric artery
Ugo Boggi et al.
BRITISH JOURNAL OF SURGERY (2023)
ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody
Sai Kiran Sharma et al.
CLINICAL CANCER RESEARCH (2022)
MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion
Saravanakumar Marimuthu et al.
MOLECULAR CANCER RESEARCH (2022)
Feasibility of cold triangle robotic pancreatoduodenectomy
Emanuele F. Kauffmann et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2022)
Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection
Niccolo Napoli et al.
UPDATES IN SURGERY (2021)
Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019
Longfei Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer
Lingdi Yin et al.
MEDICAL ONCOLOGY (2020)
Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer
Yoshiyasu Kato et al.
HPB (2019)
Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma
Louisa Bolm et al.
HPB (2019)
MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer
Kun Fan et al.
CANCER LETTERS (2018)
RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling
Zi-Hao Qi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2018)
Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma
Chen Liang et al.
MOLECULAR CANCER RESEARCH (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer
Guopei Luo et al.
ANNALS OF SURGERY (2017)
Very high serum levels of CA 19-9 in autoimmune pancreatitis: Report of four cases and brief review of literature
Giulia De Marchi et al.
JOURNAL OF DIGESTIVE DISEASES (2016)
Robotic pancreatoduodenectomy with vascular resection
Emanuele F. Kauffmann et al.
LANGENBECKS ARCHIVES OF SURGERY (2016)
Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
Chen Liu et al.
ONCOTARGET (2016)
Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden
Liang Liu et al.
ONCOTARGET (2016)
A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer
Liang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Franck Bonnetain et al.
EUROPEAN JOURNAL OF CANCER (2014)
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Mildred Felder et al.
MOLECULAR CANCER (2014)
The Comprehensive Complication Index A Novel Continuous Scale to Measure Surgical Morbidity
Ksenija Slankamenac et al.
ANNALS OF SURGERY (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Improvement of surgical results for pancreatic cancer
Werner Hartwig et al.
LANCET ONCOLOGY (2013)
Pancreatic cancer and predictors of survival: comparing the CA 19-9/bilirubin ratio with the McGill Brisbane Symptom Score
Sinziana Dumitra et al.
HPB (2013)
Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
Shih-Hsun Chen et al.
SCIENTIFIC REPORTS (2013)
Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma
Atsushi Shimizu et al.
CANCER SCIENCE (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Early Recurrence of Pancreatic Cancer after Resection and During Adjuvant Chemotherapy
Richard Fischer et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2012)
Pancreatic Cancer Surgery in the New Millennium Better Prediction of Outcome
Werner Hartwig et al.
ANNALS OF SURGERY (2011)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer
Ugo Boggi et al.
SURGERY (2009)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
K. S. Goonetilleke et al.
EJSO (2007)
Redefining the R1 resection in pancreatic cancer
C. S. Verbeke et al.
BRITISH JOURNAL OF SURGERY (2006)
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings
S Hishinuma et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Share Paper
